Wu SM - Search Results

1

The Role of EREG/EGFR Pathway in Tumor Progression.

Cheng WL, Feng PH, Lee KY, Chen KY, Sun WL, Van Hiep N, Luo CS, Wu SM. Cheng WL, et al. Among authors: wu sm. Int J Mol Sci. 2021 Nov 27;22(23):12828. doi: 10.3390/ijms222312828. Int J Mol Sci. 2021. PMID: 34884633 Free PMC article. Review.

2

Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones.

Huang YH, Lee CY, Tai PJ, Yen CC, Liao CY, Chen WJ, Liao CJ, Cheng WL, Chen RN, Wu SM, Wang CS, Lin KH. Huang YH, et al. Among authors: wu sm. Endocrinology. 2006 May;147(5):2481-9. doi: 10.1210/en.2005-1166. Epub 2006 Feb 9. Endocrinology. 2006. PMID: 16469813

3

Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion.

Liao CH, Yeh SC, Huang YH, Chen RN, Tsai MM, Chen WJ, Chi HC, Tai PJ, Liao CJ, Wu SM, Cheng WL, Pai LM, Lin KH. Liao CH, et al. Among authors: wu sm. Endocr Relat Cancer. 2010 Jan 29;17(1):99-111. doi: 10.1677/ERC-09-0050. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19903741

4

Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines.

Wu SM, Huang YH, Lu YH, Chien LF, Yeh CT, Tsai MM, Liao CH, Chen WJ, Liao CJ, Cheng WL, Lin KH. Wu SM, et al. Cell Mol Life Sci. 2010 Jun;67(11):1831-43. doi: 10.1007/s00018-010-0281-2. Epub 2010 Feb 10. Cell Mol Life Sci. 2010. PMID: 20146079

5

Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells.

Liao CH, Yeh CT, Huang YH, Wu SM, Chi HC, Tsai MM, Tsai CY, Liao CJ, Tseng YH, Lin YH, Chen CY, Chung IH, Cheng WL, Chen WJ, Lin KH. Liao CH, et al. Among authors: wu sm. Hepatology. 2012 Mar;55(3):910-20. doi: 10.1002/hep.24740. Epub 2012 Jan 13. Hepatology. 2012. PMID: 21994129

6

Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance.

Tsai MM, Lin PY, Cheng WL, Tsai CY, Chi HC, Chen CY, Tseng YH, Cheng YF, Chen CD, Liang Y, Liao CJ, Wu SM, Lin YH, Chung IH, Wang CS, Lin KH. Tsai MM, et al. Among authors: wu sm. Cancer Sci. 2012 Jun;103(6):1136-44. doi: 10.1111/j.1349-7006.2012.02243.x. Epub 2012 Mar 28. Cancer Sci. 2012. PMID: 22348287 Free PMC article.

7

Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.

Cheng WL, Tsai MM, Tsai CY, Huang YH, Chen CY, Chi HC, Tseng YH, Chao IW, Lin WC, Wu SM, Liang Y, Liao CJ, Lin YH, Chung IH, Chen WJ, Lin PY, Wang CS, Lin KH. Cheng WL, et al. Among authors: wu sm. PLoS One. 2012;7(3):e34352. doi: 10.1371/journal.pone.0034352. Epub 2012 Mar 29. PLoS One. 2012. PMID: 22479608 Free PMC article.

8

Thyroid hormone actions in liver cancer.

Wu SM, Cheng WL, Lin CD, Lin KH. Wu SM, et al. Cell Mol Life Sci. 2013 Jun;70(11):1915-36. doi: 10.1007/s00018-012-1146-7. Epub 2012 Sep 6. Cell Mol Life Sci. 2013. PMID: 22955376 Review.

9

Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth.

Wu SM, Cheng WL, Liao CJ, Chi HC, Lin YH, Tseng YH, Tsai CY, Chen CY, Lin SL, Chen WJ, Yeh YH, Huang CY, Chen MH, Yeh YC, Lin KH. Wu SM, et al. Int J Cancer. 2015 Jul 1;137(1):37-49. doi: 10.1002/ijc.29368. Epub 2014 Dec 10. Int J Cancer. 2015. PMID: 25430639 Free article.

10

Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.

Wu SM, Lin SL, Lee KY, Chuang HC, Feng PH, Cheng WL, Liao CJ, Chi HC, Lin YH, Tsai CY, Chen WJ, Yeh CT, Lin KH. Wu SM, et al. Int J Cancer. 2017 Apr 1;140(7):1581-1596. doi: 10.1002/ijc.30559. Epub 2017 Jan 19. Int J Cancer. 2017. PMID: 27925179 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

908 results

Search Page